Rescriptor (delavirdine), another antiviral for HIV
May 1997
The FDA just approved Rescriptor (delavirdine), another antiviral for HIV. It's similar to Viramune (nevirapine).
If you have HIV patients coming to you for other medical needs, watch for drug interactions. Be careful prescribing other drugs for patients on Rescriptor. It's prone to drug interactions.
Rescriptor can slow the metabolism of Seldane...Hismanal...Propulsid...certain sedative hypnotics...antiarrhythmics...calcium channel blockers...ergot alkaloids...and amphetamines.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote